1 active not recruiting, 1 not yet recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Foreign-Body Reaction: new trials by email Literature Review of Foreign-Body Reaction trials Research Report on Foreign-Body Reaction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The GranStone Trial empagliflozin (Jardiance) 25 mg, Losartan 100 mg - Paraffinoma, Granuloma, Foreign-Body | Phase 2 / Phase 3 | Not yet recruiting | Martin Blomberg Jensen | 100 | 2026-09-01 | 2026-09-18 |
| Local Antibiotics for Breast Implants Gentamicin, Cefazolin and Vancomycin, Placebo - Implant Complication, Implant Infection | Phase 3 | Active not recruiting | Mikkel Herly | 1003 | 2021-01-27 | 2026-09-29 |
Granuloma, Foreign-Body (1) · Hypercalcemia (1) · Implant Capsular Contracture (1) · Nephrocalcinosis (1) · Nephrolithiasis (1)
Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Calcinosis (1) · Calcium Metabolism Disorders (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Foreign Bodies (1) · Granuloma (1) · Inflammation (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Postoperative Complications (1)
Cefazolin (1) · Gentamicins (1) · Losartan (1) · Vancomycin (1) · empagliflozin (1)
Martin Blomberg Jensen (1) · Mikkel Herly (1)
Denmark (2)
Martin B Jensen, Professor (1) · Mikkel Herly, MD, Ph.D. (1)